Ibrutinib is a new and effective treatment for relapsed chronic lymphocytic leukaemia
Dr John Byrd discusses a new treatment involving Ibrutinib which has been FDA and EC approved in 2014 for the treatment of relapsed chronic lymphocytic leukaemia.
A new way of treating the benign breast disease granulomatous mastitis
Dr Alajmi Adil Aljarrah talks about a new way of treating granulomatous mastitis, a benign breast disease, with the use of antibiotics.
Reduced use of statins can improve quality of life in end of life care
Prof Abernethy talks about the new findings from a federally funded randomised study which indicate that it is safe to stop statin therapy in patients with a life expectancy of less than a year.
New treatment option for breast cancer patients
Dr Andrew Seidman outlines the benefits radiotherapy treatment can bring to breast cancer patients when comparing it to surgery.
The future of treating early lung cancer tumours using Stereotactic Ablative Radiotherapy (SABR)
Dr Suresh Senan discusses a new treatment which gives a high chance of a cure for some types of lung tumour.
A new treatment for relapsed chronic lymphocytic leukaemia (CLL)
Dr Jennifer Brown discusses the drug Idelalisib and it's role in improving survival with patients suffering from relapsed Chronic Lymphocytic Leukaemia (CLL).
Disclaimer: ecancerpatient has no control over the content of external websites